Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Cancer Treatment and Research|November 14, 2013
The perinucleolar compartment: RNA metabolism and cancerJohn T Norton, Sui HuangProceedings of the National Academy of Sciences of the United States of America|June 22, 2011
Role of IL-1 receptor-associated kinase-M (IRAK-M) in priming of immune and inflammatory responses by nitrogen bisphosphonatesJohn T Norton, Tomoko Hayashi, Brian Crain, et al.The Journal of Biological Chemistry|November 19, 2008
The perinucleolar compartment is directly associated with DNAJohn T Norton, Chen Wang, Alison Gjidoda, et al.Journal of Biomolecular Screening|September 19, 2009
Automated high-content screening for compounds that disassemble the perinucleolar compartmentJohn T Norton, Steven A Titus, Dwayne Dexter, et al.Cancer|June 11, 2008
Perinucleolar compartment prevalence is a phenotypic pancancer marker of malignancyJohn T Norton, Callie B Pollock, Chen Wang, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2012
Cutting edge: nitrogen bisphosphonate-induced inflammation is dependent upon mast cells and IL-1John T Norton, Tomoko Hayashi, Brian Crain, et al.The Journal of Biological Chemistry|May 24, 2008
Polypyrimidine tract-binding protein (PTB) differentially affects malignancy in a cell line-dependent mannerChen Wang, John T Norton, Supurna Ghosh, et al.Neoplasia (New York, N.Y.)|May 3, 2011
Methoxyethylamino-numonafide is an efficacious and minimally toxic amonafide derivative in murine models of human cancerYanning Liu, John T Norton, Mark A Witschi, et al.Anti-Cancer Drugs|November 29, 2007
Synthesis and anticancer activities of 6-amino amonafide derivativesJohn T Norton, Mark A Witschi, Lynn Luong, et al.Melanoma Research|October 30, 2010
Additive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2Tomoko Hayashi, Michael Chan, John T Norton, et al.Pageof 2